Zhejiang CONBA Pharmaceutical's low P/E ratio is due to its ...
Zhejiang CONBA Pharmaceutical's low P/E ratio is due to its poor earnings outlook. Shareholders accept this, anticipating no future earnings surprises. Without improvement, this will continue to hinder the share price.
![](https://pubimg-10000538.picsh.myqcloud.com/2022050900000241e2c3614fabb.jpg)
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment